Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
Amgen India investment totals $200 million through 2025
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
The company anticipates 2025 worldwide sales to be between $64.1 billion and $65.6 billion
This innovative formulation combines cutting-edge ingredients is a first of its kind in India to have a Duo-Lipo technology
Fourth-quarter 2024 revenues totaled $17.8 billion, an increase of $3.2 billion
Subscribe To Our Newsletter & Stay Updated
